1. Hemoptysis Associated With Percutaneous Transthoracic Needle Biopsy: Development of Critical Events Checklist and Procedure Outcomes
- Author
-
Mary S. Dietrich, Matthew Kennedy, Alexandra Solomon, Perri Pardini, Stephen B. Solomon, Piera C. Robson, Alan Kotin, Mohit Chawla, Terrah Foster Akard, and David O'Connor
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,Percutaneous ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Critical event ,General surgery ,Incidence (epidemiology) ,LATERAL DECUBITUS ,Interventional radiology ,030204 cardiovascular system & hematology ,Article ,Checklist ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Chart review ,medicine ,business ,Transthoracic needle biopsy - Abstract
BACKGROUND: A percutaneous transthoracic needle biopsy (PTNB) is performed to obtain tissue for a pathologic diagnosis. A PTNB is necessary prior to the initiation of many cancer treatments. There is a risk of hemoptysis, the expectoration of blood, with the possibility for adverse, life-threatening outcomes. A critical event checklist is a cognitive aid used in an emergency to ensure critical steps are followed. To date, there are no known checklists published for management of PTNB-related, life-threatening hemoptysis. The purpose of this report is to describe the development and implementation of a critical event checklist and the adoption of the checklist into hemoptysis management. METHODS: In March 2017, a process improvement team convened to evaluate the hemoptysis response using the Plan-Do-Study-Act (PDSA) methodology. The checklist was evaluated and updated through September 2019. The team educated Interventional Radiology (IR) clinicians on the new checklist and conducted simulations on its use. A retrospective chart review was performed on hemoptysis events between the ten-year period of October 1, 2008 and September 30, 2018 to evaluate the adoption of the checklist into practice. RESULTS: There were 231 hemoptysis events occurring in 229 patients (2 with repeat biopsies). Prior to implementing the protocol and checklist, there were 166 (71.9%) hemoptysis events. After implementation there were 65 (28.1%) events. The median amount of documented blood expectorated with hemoptysis was 100 mL (IQR 20.0–300.0). Twenty-six patients were admitted after PTNB for reasons related to the hemoptysis event (11.3%). During the procedure, four (1.7%) patients with hemoptysis suffered a cardiac arrest. Prior to implementation of the protocol and critical events checklist, nurses positioned patients in the lateral decubitus (LD) position in 40 out of 162 (24.7%) cases. After implementation of the critical events checklist, nurses positioned patients in the LD position 42 out of 65 cases (64.6%) (OR=5.57(95% CI 2.99–10.367), p
- Published
- 2021